Cargando…

Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity

Background: Structural damage to the hypothalamus often results in hypothalamic obesity characterized by rapid and severe weight-gain with increased risk of cardiovascular and metabolic morbidity and mortality. Currently, there are no approved or effective pharmacological treatments and conventional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huynh, Kim D, Klose, Marianne C, Krogsgaard, Kim, Drejer, Jorgen, Byberg, Sarah, Madsbad, Sten, Magkos, Faidon, Aharaz, Abdellatif, Edsberg, Berit, Tfelt-Hansen, Jacob, Astrup, Arne, Feldt-Rasmussen, Ulla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089137/ http://dx.doi.org/10.1210/jendso/bvab048.130

Ejemplares similares

Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity
por: Huynh, Kim, et al.
Publicado: (2022)

ODP350 Safety and Efficacy of Tesomet over 48 Weeks of Treatment: Results From a 24-Week Phase 2, Randomized, Double-Blind Study With 24 Week Open-Label Extension in Adults With Hypothalamic Obesity
por: Klose, Marianne, et al.
Publicado: (2022)

Hypothalamic Glucagon Receptors Regulate Feeding in Mice
por: Cunningham, Stephen E, et al.
Publicado: (2021)

Dextroamphetamine Treatment for Children With Hypothalamic Obesity
por: van Schaik, Jiska, et al.
Publicado: (2021)

SUN-101 Dysregulation of Hypothalamic Gene Expression by Soybean Oil Diets in Mice
por: Deol, Poonamjot, et al.
Publicado: (2019)

FRI082 Impact Of Setmelanotide On Metabolic Parameters And Vital Signs In Patients With Hypothalamic Obesity
por: Jennifer Abuzzahab, M, et al.
Publicado: (2023)

SUN-114 Microglia Interact with Hypothalamic Progenitors during Development and Are Required for Proper Energy Balance
por: Rosin, Jessica, et al.
Publicado: (2019)

SAT-602 Hypothalamic P75 Neurotrophin Receptor Regulates Homeostatic Feeding and Food Anticipation
por: Podyma, Brandon, et al.
Publicado: (2020)

SAT656 Weight Reduction After 6 Months Of Setmelanotide Treatment In Patients With Hypothalamic Obesity
por: Roth, Christian L, et al.
Publicado: (2023)

FRI064 The Role Of GLP-1 Receptor Agonists In The Treatment Of Pituitary And Hypothalamic Tumor Induced Obesity
por: Botero Suarez, Carlos S, et al.
Publicado: (2023)

SUN-LB018 Role of BMAL1 in Western Diet-Induced Disruption of Circadian Hypothalamic Feeding Neuropeptides
por: Clemenzi, Matthew, et al.
Publicado: (2019)

Fatty Acids Modify the MicroRNA Content of Exosomes Released by Hypothalamic Astrocytes and the Response of POMC Neurons to These Exosomes
por: Collado-Pérez, Roberto, et al.
Publicado: (2021)

FRI066 Treatment History And Comorbidities Reported By Patients With Hypothalamic Obesity Treated With Setmelanotide In A Phase 2 Trial
por: Roth, Christian L, et al.
Publicado: (2023)

SUN-120 Influences Of Peri-implantation Ozone Exposure And Post-natal High Fat Diet On Energy Balance And Hypothalamic DNA Methylation.
por: Miller, Colette, et al.
Publicado: (2019)

FRI065 Trial Design Of A Double-blind, Randomized, Placebo-controlled, Phase 3 Study Of Setmelanotide In Patients With Hypothalamic Obesity
por: Roth, Christian L, et al.
Publicado: (2023)

SAT-597 Hypothalamic ESR1 Gene Knockdown Elicits Intermittent Decrement in Postprandial Energy Expenditure Associated with Obesity Onset in Female Rhesus Monkeys
por: Willging, Molly, et al.
Publicado: (2020)

SUN-096 Hypothalamic ATP Has a Crucial Role in the Pathogenesis of Leptin Resistance: A Potential Mechanism for the Amelioration of Leptin Resistance by Celastrol and Withaferin A
por: Ebihara, Chihiro, et al.
Publicado: (2019)

FRI026 PPARγ Antagonists Induce Aromatase Transcription In Human Adipose Tissue Cells
por: Ardenkjær-Skinnerup, Jacob, et al.
Publicado: (2023)

MON-112 Gelesis100 Reduces Insulin Resistance in Patients Who Are Overweight or Have Obesity with High Insulin Resistance: Results of the GLOW Study
por: Greenway, Frank, et al.
Publicado: (2019)

SAT-LB023 Elevated Fasting Plasma Glucose Predicts Higher Odds For Becoming A Super-responder With Gelesis100 In The GLOW Pivotal Weight-loss Study
por: Greenway, Frank, et al.
Publicado: (2019)

SAT672 Dulaglutide Might Reduce Visceral Fat In Patients With Metabolic Syndrome
por: Kim, Yu Na
Publicado: (2023)

FRI035 Comparative Study Of The Changes In Body Composition According To Age And The Associations With The Risk Of Diabetes Mellitus By Races
por: Jang, Seol A, et al.
Publicado: (2023)

SUN-587 IDH1-Dependent Alpha-KG Regulates Brown Fat Differentiation and Function by Modulating Histone Methylation
por: Kim, Won Kon, et al.
Publicado: (2020)

FRI049 Correlation Between Tri-Ponderal Mass Index And Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-3 In Children And Adolescent
por: Choi, Iee Ho, et al.
Publicado: (2023)

FRI070 The Urinary Extracellular Vesicles Small RNA Profile Of Obesity Displays Distinct Patterns By RNA Subclass
por: Choi, Dughyun, et al.
Publicado: (2023)

Developmental Changes in Food Perception and Preference
por: Serrano-Gonzalez, Monica, et al.
Publicado: (2021)

SUN-110 The Role Of RasD2 In Metabolism And Obesity
por: Fong, Vincent, et al.
Publicado: (2019)

Activin A Plays a Critical Role in Adipose Tissue Wasting in the Progression of Cancer Cachexia
por: Luan, Yi, et al.
Publicado: (2021)

FRI037 Time-restricted Feeding Prevents Progression Of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Through IPMK
por: Jung, Ik-Rak, et al.
Publicado: (2023)

Pancreatic Ductal Adenocarcinoma Highly Expresses Activin A: Implications in Adipose Tissue and Cancer Cachexia
por: Xu, Pauline, et al.
Publicado: (2021)

SUN-115 Role of Olfactory Marker Protein in High-Fat, Diet-Induced Obese Models
por: Oh, Ju Hun, et al.
Publicado: (2019)

MON-591 Effect of Liraglutide Treatment on Proglucagon-Derived Peptides
por: Kim, Sun, et al.
Publicado: (2020)

SUN-LB104 Metabolic Inflexibility: Is It a Feature of Obesity or a Characteristic of Metabolically Unhealthy Youth?
por: Gebara, Nour Y, et al.
Publicado: (2020)

SAT-591 Lack of Adipose-Specific Hexose-6-Phosphate Dehydrogenase Improves Fat Metabolic Phenotype and Increases Insulin Sensitivity in Mice
por: Wang, Jian, et al.
Publicado: (2020)

SUN-092 Distinct Changes in Gut Microbiota Are Associated with Estradiol-Mediated Protection from Diet-Induced Obesity in Female Mice
por: Acharya, Kalpana, et al.
Publicado: (2019)

FRI005 Appetite Response To Short-term Energy Restriction In Young Healthy Women
por: Choi, Gloria E, et al.
Publicado: (2023)

Renal Outcomes One Year After Metabolic Bariatric Surgery: A Clinical Audit
por: Wee, Zongwen, et al.
Publicado: (2021)

SAT669 Development And Biophysical Characterization Of A Humanized FSH-blocking Monoclonal Antibody Therapeutic Formulated At An Ultra-high Concentration
por: Rojekar, Satish, et al.
Publicado: (2023)

Obesity and Covid-19: A Major Mortality Risk in Patients Hospitalized With Covid-19
por: Rodriguez, Giovanna, et al.
Publicado: (2021)

SAT668 Can We Treat Osteoporosis, Obesity And Neurodegeneration With A Single FSH-blocking Drug?
por: Rani Pallapati, Anusha Rani, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7g9aon9v6rbh9bu36u9ijqvti6